Last reviewed · How we verify
Benzoyl peroxide with clindamycin and doxycycline — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Benzoyl peroxide with clindamycin and doxycycline (Benzoyl peroxide with clindamycin and doxycycline) — Stiefel, a GSK Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Benzoyl peroxide with clindamycin and doxycycline TARGET | Benzoyl peroxide with clindamycin and doxycycline | Stiefel, a GSK Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Benzoyl peroxide with clindamycin and doxycycline CI watch — RSS
- Benzoyl peroxide with clindamycin and doxycycline CI watch — Atom
- Benzoyl peroxide with clindamycin and doxycycline CI watch — JSON
- Benzoyl peroxide with clindamycin and doxycycline alone — RSS
Cite this brief
Drug Landscape (2026). Benzoyl peroxide with clindamycin and doxycycline — Competitive Intelligence Brief. https://druglandscape.com/ci/benzoyl-peroxide-with-clindamycin-and-doxycycline. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab